Emerging Trends in the Electrosurgery Industry

Introduction:

The electrosurgery industry is undergoing significant transformation, driven by advancements in technology, growing demand for minimally invasive procedures, and increasing healthcare expenditure. Here are the key emerging trends shaping the future of this sector:

1. Technological Advancements:

The electrosurgery market is experiencing rapid technological innovations. Enhanced electrosurgical devices now offer greater precision, safety, and efficiency. These advancements include the integration of advanced energy sources like ultrasonic and radiofrequency technologies, which allow for more precise cutting and coagulation with minimal thermal damage to surrounding tissues. Additionally, the development of intelligent electrosurgical systems equipped with feedback mechanisms ensures optimal energy delivery, reducing the risk of complications.

2. Rise of Minimally Invasive Surgery:

Minimally invasive surgical (MIS) techniques are increasingly preferred over traditional open surgeries due to their numerous benefits, including reduced pain, shorter hospital stays, and quicker recovery times. Electrosurgery plays a crucial role in MIS by enabling surgeons to perform delicate procedures through small incisions. The trend towards MIS is expected to continue, driving the demand for advanced electrosurgical instruments.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=142006761

3. Integration with Robotics and AI:

The integration of robotic-assisted surgical systems and artificial intelligence (AI) is revolutionizing the electrosurgery field. Robotic systems provide enhanced dexterity and precision, while AI algorithms assist in planning and executing complex surgical procedures. This combination enhances surgical outcomes and expands the capabilities of electrosurgical techniques in complex and delicate operations.

4. Growing Applications in Various Medical Specialties:

Electrosurgery is being increasingly utilized across various medical specialties, including dermatology, gastroenterology, gynecology, and oncology. In dermatology, for instance, electrosurgical devices are used for the removal of skin lesions and in cosmetic procedures. In oncology, electrosurgery aids in the precise removal of tumors while preserving healthy tissue. This diversification of applications is broadening the market's scope and driving growth.

5. Emphasis on Patient Safety and Regulatory Compliance:

With the growing focus on patient safety, regulatory bodies are imposing stringent guidelines for the approval and use of electrosurgical devices. Manufacturers are required to adhere to rigorous standards to ensure the safety and efficacy of their products. This trend is leading to the development of devices with improved safety features, such as automated energy control and real-time monitoring systems.

6. Market Growth and Strategic Collaborations:

The global electrosurgery market is projected to witness significant growth, driven by increasing healthcare expenditure, rising prevalence of chronic diseases, and the growing geriatric population. Companies are engaging in strategic collaborations, mergers, and acquisitions to expand their product portfolios and geographical presence. These collaborations are fostering innovation and enabling companies to meet the evolving needs of the healthcare industry.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=142006761

Conclusion:

The electrosurgery industry is at the forefront of surgical innovation, with emerging trends focused on enhancing precision, safety, and efficiency. The ongoing advancements in technology, coupled with the rising demand for minimally invasive procedures and strategic industry collaborations, are set to drive the growth of the electrosurgery market in the coming years.

Future Growth Trends in Pharmaceutical Drug Delivery

Major Growth Influencing Factors:

Increased R&D spending, the expanding biologics market, the emergence of new products, the growing prevalence of chronic illnesses, and technology breakthroughs are all major contributors to the growth of the pharmaceutical drug delivery sector. Additionally, research and development (R&D) is a priority for pharmaceutical and biopharmaceutical businesses as they create novel compounds for a range of therapeutic uses and drug delivery systems.

The companies invest heavily in R&D with the aim of delivering high-quality and innovative products to the market. R&D spending by biopharmaceutical companies has also increased over the years. On the other hand, the risk of needlestick injuries and the increased pricing pressure are expected to limit the market's growth to some extent in the coming years.

Market Size Estimation:

Following data triangulation from various methods, the pharmaceutical medication delivery market's overall size was determined, as will be discussed below. Based on the degree of assumptions made in each method, a weighted average of the techniques was determined after each one.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1085

Major Surge in Global Revenue:

The size of global pharmaceutical drug delivery market in terms of revenue was estimated to be worth $1,656.9 billion in 2021 and is poised to reach $2,206.5 billion by 2026, growing at a CAGR of 5.9% from 2021 to 2026.

Data Triangulation:

After arriving at the market size, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.

Opportunity: Self-management and in-home care

Players in the pharmaceutical drug delivery market could see substantial growth prospects from self-administration and home care. The primary cause of this is the growing geriatric population, as they represent a significant market for home care medication delivery equipment. This aspect is also driving up demand for application-specific topical, injectable, inhalation, and transdermal medication treatments that meet patients' and caregivers' demands.

Challenge: Pressure on prices

Government agencies are pushing cost-cutting initiatives including lowering prescription reimbursement rates and encouraging the use of generics more frequently in both developed and developing nations. Government agencies, insurers, and patients are putting tremendous pressure on drug makers worldwide to reduce costs. Because there is a significant demand for affordable treatments in emerging countries, there is a greater adoption of pharmaceuticals as a result of this lower pricing pressure.

Still, this is hurting a number of pharmaceutical companies' bottom lines. Due to constant pressure from pharmacy benefit managers (PBMs), insurers, and public and private payers to lower pharmaceutical prices because they are worried about paying for more new medications to treat common conditions like diabetes and high cholesterol, this trend is anticipated to continue in the upcoming years.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=1085

Geographical Growth Scenario:

North America will dominate the pharmaceutical drug delivery industry from 2021–2026

Geographically, the global pharmaceutical drug delivery market is segmented into North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. North America accounted for the largest share of this market in 2020. The high share of the North American market is attributed to the rising prevalence of chronic diseases, such as cancer, respiratory allergies, and diabetes; increasing patient compliance with innovative drug delivery technologies; and the presence of a large number of prominent players in this region.

Dental Consumables Market - Major Revenue Surge is Predicted in Near Future

Major Growth Driving Factors:

Growing tooth repair procedures, rising demand for improved aesthetic dental procedures, expanding dental tourism in emerging markets, and the development of innovative solutions are all factors boosting the global market for dental consumables. However, issues including high dental implant costs and low reimbursements may impede market growth to some extent over the course of the projection period.

Projected Surge in Global Revenue:

The global dental consumables market in terms of revenue was estimated to be worth $35.3 billion in 2022 and is poised to reach $55.7 billion by 2027, growing at a CAGR of 9.5% from 2022 to 2027.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=699

Global Industry Segmentation:

By Product, the dental restoration segment is expected to account for the largest share of the dental consumables market

The dental restoration segment accounted for the largest share of the global dental consumables market in 2021. The growing prevalence of edentulism across the world and growing demand for implants and cosmetic dentistry are driving the growth of the dental consumables market. The dental restoration procedures comprised of dental specialty treatment such as prosthodontic dentistry, including fillings, veneers, crowns, bridges, full and partial dentures and dental implants. Surging volume of patients suffering from dental disorders, surging consumption of dental restorative materials among adults, increasing demand for the restorative material or the conservation of tooth structure are some of the major factors which will likely to augment the growth of the dental restoration segment.

End Users:

By End User, the dental hospitals and clinics segment is expected to account for the largest share of the dental consumables market

The dental hospitals and clinics segment accounted for the largest share of the global dental consumables market in 2021. The large share of this segment can be attributed to the increasing number of dental clinics and hospitals across emerging markets, increasing enrollment in dental courses and the high number of freshly passed out dental students per year. For instance, according to data published by NCBI, in 2019, 2.7 lakh dentists were registered with the Dental Council of India (DCI) per year.

Regional Growth Segmentation:

Europe to dominate the dental consumables market during the forecast period

Europe is the largest regional market for dental consumables with respect to market share in 2021. The growing geriatric population, increasing government expenditure on oral healthcare, and the growing number of group dental practices are the key factors driving the growth of the dental consumables market in Europe.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=699

Opportunity: Growing focus on emerging markets & rising disposable income levels

The penetration rate of dental implants is very low in most developing countries and certain developed countries, such as the UK and Germany. Large and emerging economies such as China and India have a low penetration rate for dental implants due to the high cost of dental implant procedures and a lack of qualified dental professionals. According to Institut Straumann, only 15–20% of the 1.2 million active dentists across the globe perform implant procedures, with South Korea and Italy having the highest penetration rate of dental implants. The untapped market potential in these regions offers significant opportunities for players operating in this arena.

Additionally, favorable government policies and initiatives attract several industry stakeholders to these markets. For instance, reducing customs duty for dental products from 16 to 8% in India has opened avenues for international players. Furthermore, in China, the government’s deregulation and relaxation of norms for setting up private healthcare facilities have boosted the number of privately owned dental clinics. Such government initiatives in emerging economies will encourage the adoption of advanced technologies, such as CAD/CAM systems and high-quality restoration products and materials.

Pharmaceutical Drug Delivery: Emerging Trends to Bring Major Transformation in Near Future

Overview of This Study:

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Revenue Growth Predictions:

With a compound annual growth rate (CAGR) of 5.9%, the global pharmaceutical medication delivery industry is expected to reach $2,206.5 billion by 2026 from its anticipated $1,656.9 billion in revenue in 2021. The research report includes a price analysis, patent analysis, conference and webinar materials, important stakeholders, purchasing patterns in the market, and an analysis of industry trends.

Major Growth Driving Factors:

Growth in the pharmaceutical drug delivery industry can largely be attributed to factors such as the rising prevalence of chronic diseases, the growing biologics market, increasing R&D investments, technological advancements, and new product launches. Moreover, pharmaceutical and biopharmaceutical companies are focusing on R&D to develop new molecules for various therapeutic applications and drug delivery platforms. The companies invest heavily in R&D with the aim of delivering high-quality and innovative products to the market. R&D spending by biopharmaceutical companies has also increased over the years. On the other hand, the risk of needlestick injuries and the increased pricing pressure are expected to limit the market's growth to some extent in the coming years.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1085

The infectious disease segment accounted for the largest share of the pharmaceutical drug delivery industry

On the basis of application, the pharmaceutical drug delivery market is segmented into cancer, infectious diseases, cardiovascular diseases, diabetes, respiratory diseases, central nervous system disorders, autoimmune diseases, and other applications. In 2020, the infectious diseases segment accounted for the largest share of the global market. The large share of this market segment can be attributed to the increasing prevalence of infectious diseases across the globe, increasing R&D expenditure for new drugs owing to the current COVID-19 pandemic scenario, and the rising number of FDA approvals for such drugs.

Geographical Growth Dynamics:

From 2021 to 2026, North America will lead the pharmaceutical drug delivery sector.

The pharmaceutical drug delivery market is divided geographically into the following regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In 2020, North America held the biggest market share in this industry. The rising incidence of chronic illnesses like diabetes, cancer, and respiratory allergies as well as patient compliance with novel drug delivery technologies and the concentration of major players in this region are all considered to be contributing factors to the market's high share in North America.

Driver: Growth in biologics market

Enterprises like Evonik (Germany) have realized the potential of biologics production and have taken significant strategic steps forward. For example, in 2021 the business acquired SurModics, a company that specializes in controlled-release parenteral applications, in order to expand its production capacity. To further strengthen its position in this industry, Evonik also purchased related technology, such as the RESOMER platform from Boehringer Ingelheim. In a similar vein, WuXi Biologics and Shanghai Hile Bio-Technology Co., Ltd. announced the establishment of WuXi Vaccines in 2019. The two businesses forged a strategic alliance whereby WuXi Vaccines will construct a special facility and provide a commercial product for the international market. A new class of medicines has emerged in the biopharmaceutical industry, demonstrating great promise for novel therapies in diabetes, cancer, and other disease areas.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=1085

Leading Companies:

Major players in this market include Johnson & Johnson (US), Novartis International AG (Switzerland), F. Hoffmann-La Roche AG (Switzerland), Pfizer Inc. (US), Bayer AG (Germany), Antares Pharma, Inc. (US), Becton, Dickinson and Company (US), GlaxoSmithKline plc (UK), 3M (US), Merck & Co., Inc. (US), Sanofi (France), Amgen, Inc. (US), AbbVie Inc. (US), Genmab A/S (Denmark), Gilead Sciences, Inc. (US), Boehringer Ingelheim (Germany), AstraZeneca plc. (UK), Eli Lilly and Company (US), Teva Pharmaceuticals Industries Ltd. (Israel), Bristol-Myers Squibb (US), Gerresheimer AG (Germany), Boston Scientific Corporation (US), Nimbus Therapeutics (US), Kite Pharma (US), and IDEAYA Biosciences, Inc. (US).

Tablet Coatings Market - Emerging Trends to Bring Major Revolution in Global Healthcare Industry

Market Size Estimation:

This study's market size estimations and forecasts are the result of combining a top-down (evaluation of utilization/adoption/penetration trends by polymer type, functionality, type, end user, and region) and bottom-up (segmental analysis of important segments) methodology.

Projected Surge in Revenue Generation:

With a compound annual growth rate (CAGR) of 5.6%, the tablet coatings market is expected to reach a valuation of USD 969 million by 2025 from its estimated USD 739 million in 2020.

Major Growth Boosting Factors:

The pharmaceutical industry's growth and the rise in R&D in this area are the main factors driving this market's expansion. The market is expanding thanks to the burgeoning nutraceutical business, the fast expanding biopharmaceuticals sector, the growing generics market, and the increased use of orphan medications. Furthermore, there are a lot of prospects for market expansion due to the pharmaceutical industry's growing emphasis on emerging markets and the growing outsourcing of operations to these nations. The growing emphasis on technology developments in specialized markets also presents large growth prospects for companies involved in this industry.

However, throughout the projected period, the market's expansion is anticipated to be constrained by the tightening regulations pertaining to the licensing of pharmaceuticals and excipients, as well as the high cost of the microencapsulation process.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=150774403

Data Triangulation:

The entire tablet coatings market was split into a number of categories and subsegments when the market size was determined. In order to finalize the market engineering process and obtain precise statistics for every segment and subsegment, data triangulation and market breakdown techniques were utilized, if appropriate.

End Users:

The pharmaceutical industry end-user segment is expected to account for the largest share of the tablet coatings market

The tablet coatings market, by end-user, is segmented into pharmaceutical and nutraceutical industry. The pharmaceutical industry segment accounted for the largest market share in 2019. The demand for tablet coatings in the pharmaceutical industry is largely driven by the increasing number of drugs launched as tablet formulations and growing prevalence of diseases for which tablet-based formulations form the primary treatment. The rising demand for innovative drug delivery formulations is also supporting the growth of the tablet coatings market for the pharmaceutical industry.

Geographical Growth Dynamics:

Asia Pacific is expected to account for the highest CAGR for players operating in the tablet coatings market

The Asia Pacific tablet coatings market is expected to grow at the highest CAGR from 2020 to 2025. Increase in outsourcing of drug manufacturing to specialized contract manufacturing organizations (CMOs), rising number of companies setting up manufacturing units in these countries, favorable government regulations, low labor and manufacturing costs, and the large base for the generation of generics & biologics are factors expected to drive the growth of the market during the forecast period.

Global Key Players:

The prominent players in this market are Colorcon Inc. (US), Sensient Technologies Corporation (US), BASF SE (Germany), Evonik Industries AG (Germany), Ashland Global Holdings Inc. (US), DuPont De Numeours Inc. (US), Kerry Group plc (Ireland), Roquette Freres (France), Eastman Chemical Company (US), Air Liquide S.A. (France), and Merck KGaA (Germany).

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=150774403

Contrast Media Market: A Major Revenue Surge is Predicted at a CAGR of 7.5% by 2029

Overview of this Study:

Analyzing the main market dynamics, including opportunities, challenges, constraints, drivers, and key player tactics, is the study's goal. The competitive landscape of the contrast media market is being monitored in order to keep tabs on business activities, including new launches, approvals, expansions, and partnerships of the dominant players. Additionally, market participants are being analyzed on a number of characteristics within the broad categories of business and product strategy. Two methods were employed to estimate the market size: top-down and bottom-up. The market split and data triangulation were used to estimate the market sizes of the various segments and subsegments.

Principal Growth-Inducing Factors:

Growing numbers of hospitals and diagnostic imaging facilities, increased awareness of early diagnosis, and an increase in the prevalence of chronic illnesses are the main factors driving market expansion. Conversely, the negative consequences linked to the usage of contrast media will limit this market's expansion somewhat.

Projected Surge in Global Revenue:

According to revenue estimates, the global contrast media market will be valued $6.3 billion in 2023 and is expected to rise at a compound annual growth rate (CAGR) of 7.5% to reach $9.7 billion by 2029.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911

Global Industry Segmentation:

By application, the radiology segment held the biggest proportion of the contrast media market in 2022.

The contrast media market is divided into three segments based on application: interventional radiology, radiology, and interventional cardiology. By application, radiology held the biggest market share in 2022. radiological contributes to the increased demand for radiological operations by being essential in the early detection and monitoring of a variety of medical problems. The growing number of elderly people, the occurrence of chronic illnesses, and the need for minimally invasive procedures are just a few of the reasons for the high percentage of radiology applications.

By route of administration, the intravascular route segment held the biggest proportion of the contrast media market in 2022.

The global contrast media market is divided into intravascular, oral, rectal, and other routes of administration based on the mode of administration. According to the mode of administration, the intravascular route segment had the biggest market share in 2022. The reason for the segment's expansion is because, in contrast to powdered forms, injectable contrast media are more readily available and require less time to administer.

End Users:

According to end users, the Hospitals, Clinics, and Ambulatory Surgical Centers segment held the highest share in the contrast media industry in 2022.

The contrast media market is divided into categories based on the end user, including diagnostic imaging facilities, hospitals, clinics, and ambulatory surgical centers. The global market share held by hospitals, clinics, and ambulatory surgery facilities was the highest in 2022. The need for contrast media is increased because hospitals often make larger investments in and keep a wider variety of cutting-edge imaging equipment, including CT scanners, MRI machines, and interventional radiology suites.

Geographical Growth Scenario:

The contrast media industry's largest share was held by North America in 2022.

There are four main regions that make up the contrast media market: North America, Europe, Asia Pacific, and the Rest of the World. With the most market share in 2022, North America emerged as the top contributor. The number of product approvals in the region has increased as a result of the presence of significant businesses. These North American-based businesses have a wealth of experience, resources, and established sales networks, which help explain the region's market supremacy.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=911

Global Leading Companies:

The major players operating in this market are GE HealthCare (US), Bracco Imaging S.p.A. (Italy), Bayer AG (Germany), Guerbet (France), Lantheus Medical Imaging (US), Unijules Life Sciences Ltd. (India), JB Pharma (India), Sanochemia Pharmazeutika (Germany), TAEJOON PHARM Co., Ltd. (South Korea), Jodas Expoim (India), iMax Diagnostic Imaging Limited (Ireland), YZJ Group (China), Livealth Biopharma Pvt. Ltd. (India), Unispire Biopharma Private Limited (India), Acro Lifesciences (I) Pvt. Ltd. (India), Stanex Drugs & Chemical Pvt. Ltd. (India), Beijing Beilu Pharmaceutical Co., Ltd. (China), Rege Imaging & Cine Films Private Limited (India), K DIAM EXIM (India), Onko Ýlaç San. ve Tic. A.Þ. (Turkey), Fresenius Kabi (Germany), Biem Ilaç San. ve Tic. A.S. (Turkey), and AdvaCare (US).

Cell Isolation Market - Future Revenue Growth Looks More Promising Due to These Factors

Market Size Estimation:

Top-down approach was used to estimate and validate the total size of the cell isolation market. This method was also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

The key players in the industry and market have been identified through extensive secondary research
The revenues generated from the cell isolation products business of leading players have been determined through primary and secondary research
All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Projected Revenue Surge, Globally:

According to revenue estimates, the global cell isolation market will be valued $4.4 billion in 2023 and is expected to increase at a compound annual growth rate (CAGR) of 13.4% from 2023 to 2028, when it reaches $8.2 billion. The market's industry trends are analyzed in the latest research study.

Major Growth Driving Factors:

The market is expanding due to factors like the rise in cell-based research and the growing emphasis on personalized therapy. However, the main things impeding the growth of this market are high cost, safety concerns, and ethical considerations.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=103931479

Data Triangulation:

Following the completion of the market size assessment process, the entire market was divided into a number of segments and sub-segments. Data triangulation and market breakdown processes were used where appropriate to finish the entire market engineering process and yield precise statistics for all segments and subsegments. Through an analysis of numerous variables and patterns from the supply and demand sides, the data was triangulated.

Driver: Government support for cell-based research has increased.

The crucial first stage in the development of cell-based therapies is cell isolation. Because cell-based research has many applications, funding for these kinds of studies has been provided by numerous governments worldwide. The National Institutes of Health (NIH), for example, stated in May 2021 that funding totaling USD 30.0 million will be given to assist research targeted at creating new instruments and technology for researching cells. A number of US universities, including Harvard University, the University of California, San Francisco, and the University of Texas Southwestern Medical Center, received financing. Moreover, the Stem Cell Therapies Mission is investing USD 150.0 million over a ten-year period under the Medical Research Future Fund (MRFF) of the Government.

RESTRAINT: Ethics and safety concerns will impede commercial expansion

The embryo from which the cells are formed must be destroyed in order to isolate the embryonic stem cells. Given that some people believe an embryo to be a potential human person, this creates ethical questions regarding the taking of human life. Teratomas are tumors that comprise cells from all three germ layers, and they can be formed by embryonic stem cells. Without adequate screening, embryonic stem cells put into a patient have the potential to develop into tumors and cause damage. As a result, these elements may hinder market expansion to some degree.

Opportunity: Prospects for expansion in developing economies

The biopharmaceutical sector is expanding quickly in emerging nations like China, India, and Brazil. This is caused by a number of causes, including rising healthcare costs, an aging population, and an increase in chronic illnesses. The necessity for cell separation technologies is driving the development and manufacturing of biopharmaceuticals, as these markets see an increase in demand for these goods. Furthermore, growing markets are funding the creation and use of cutting-edge technologies including flow cytometry, magnetic cell separation, and microfluidics.

As a result, cell isolation procedures are becoming more accurate and efficient, and these technologies are becoming more widely available and reasonably priced in these markets. Additionally, there is an increasing trend in emerging markets for R&D activity. In these areas, public and private organizations are funding research to create novel cures and treatments for long-term illnesses. Since cell isolation is a crucial stage in the creation of various treatments, the market is expanding as a result of the expansion of research efforts in these areas.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=103931479

North America dominated cell isolation market in 2022.

Geographically, the market is divided geographically into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America held the greatest market share for cell isolation in 2022, followed by Europe and the Asia-Pacific region. A number of variables, including technical development, expansion of the biotechnology and pharmaceutical industries, and rising incidence of infectious and chronic diseases, account for the major share of the American market.

Leading Companies Operating in This Industry

Key players in the cell isolation market are Danaher Corporation (US), Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (US), Becton, Dickinson and Company (US), Terumo Corporation (Japan), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), Corning Incorporated (US), F. Hoffmann-La Roche Ltd. (Switzerland), Miltenyi Biotec (Germany), STEMCELL Technologies (Canada), Alfa Laval (Sweden), Sartorius AG (Germany), Akadeum Life Sciences (US), Bio-Techne (US), PerkinElmer Inc. (US), Invent Biotechnologies, Inc. (US), Takara Bio, Inc. (Japan), MiCareo Inc. (US), Proteintech Group, Inc. (US), QIAGEN (Germany), Lonza (Switzerland), Promega Corporation (US), PluriSelect Life Science UG (Haftungsbeschränkt) & Co. KG (Germany), and MagBio Genomics (US).